156 related articles for article (PubMed ID: 27772747)
1. IL-6 serum levels are elevated in Parkinson's disease patients with fatigue compared to patients without fatigue.
Pereira JR; Santos LVD; Santos RMS; Campos ALF; Pimenta AL; de Oliveira MS; Bacheti GG; Rocha NP; Teixeira AL; Christo PP; Scalzo PL
J Neurol Sci; 2016 Nov; 370():153-156. PubMed ID: 27772747
[TBL] [Abstract][Full Text] [Related]
2. The relation of testosterone levels with fatigue and apathy in Parkinson's disease.
Kenangil G; Orken DN; Ur E; Forta H; Celik M
Clin Neurol Neurosurg; 2009 Jun; 111(5):412-4. PubMed ID: 19131155
[TBL] [Abstract][Full Text] [Related]
3. [Immune factors or depression? Fatigue correlates in Parkinson's disease].
Katsarou Z; Bostantjopoulou S; Hatzizisi O; Giza E; Soler-Cardona A; Kyriazis G
Rev Neurol; 2007 Dec 16-31; 45(12):725-8. PubMed ID: 18075986
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and fatigue in early, untreated Parkinson's Disease.
Herlofson K; Heijnen CJ; Lange J; Alves G; Tysnes OB; Friedman JH; Fagundes CP
Acta Neurol Scand; 2018 Nov; 138(5):394-399. PubMed ID: 29947088
[TBL] [Abstract][Full Text] [Related]
5. Fatigue is associated with serum interleukin-6 levels and symptoms of depression in patients on chronic hemodialysis.
Bossola M; Di Stasio E; Giungi S; Rosa F; Tazza L
J Pain Symptom Manage; 2015 Mar; 49(3):578-85. PubMed ID: 25135658
[TBL] [Abstract][Full Text] [Related]
6. [Inflammatory mechanisms of fatigue syndrome in Parkinson's disease].
Baidina TV; Torgan TI; Demchuk ND; Danilova MA
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(3):61-64. PubMed ID: 26120984
[TBL] [Abstract][Full Text] [Related]
7. Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment.
Valko PO; Waldvogel D; Weller M; Bassetti CL; Held U; Baumann CR
Eur J Neurol; 2010 Dec; 17(12):1428-36. PubMed ID: 20491889
[TBL] [Abstract][Full Text] [Related]
8. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
Smith KM; Eyal E; Weintraub D;
JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid inflammatory markers in Parkinson's disease--associations with depression, fatigue, and cognitive impairment.
Lindqvist D; Hall S; Surova Y; Nielsen HM; Janelidze S; Brundin L; Hansson O
Brain Behav Immun; 2013 Oct; 33():183-9. PubMed ID: 23911592
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 serum levels in patients with Parkinson's disease.
Hofmann KW; Schuh AF; Saute J; Townsend R; Fricke D; Leke R; Souza DO; Portela LV; Chaves ML; Rieder CR
Neurochem Res; 2009 Aug; 34(8):1401-4. PubMed ID: 19214748
[TBL] [Abstract][Full Text] [Related]
11. Association of Parkinson's disease-related pain with plasma interleukin-1, interleukin-6, interleukin-10, and tumour necrosis factor-α.
Li D; Song X; Huang H; Huang H; Ye Z
Neurosci Lett; 2018 Sep; 683():181-184. PubMed ID: 30063943
[TBL] [Abstract][Full Text] [Related]
12. Plasma IL-6 and IL-17A Correlate with Severity of Motor and Non-Motor Symptoms in Parkinson's Disease.
Green HF; Khosousi S; Svenningsson P
J Parkinsons Dis; 2019; 9(4):705-709. PubMed ID: 31524180
[TBL] [Abstract][Full Text] [Related]
13. Decreased serum proNGF concentration in patients with Parkinson's disease.
Xu XM; Dong MX; Feng X; Liu Y; Pan JX; Jia SY; Cao D; Wei YD
Neurol Sci; 2018 Jan; 39(1):91-96. PubMed ID: 29052090
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fatigue in Parkinson's disease using the Brazilian version of Parkinson's Fatigue Scale.
Kummer A; Scalzo P; Cardoso F; Teixeira AL
Acta Neurol Scand; 2011 Feb; 123(2):130-6. PubMed ID: 20456242
[TBL] [Abstract][Full Text] [Related]
15. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance.
Scalzo P; Kümmer A; Cardoso F; Teixeira AL
Neurosci Lett; 2010 Jan; 468(1):56-8. PubMed ID: 19857551
[TBL] [Abstract][Full Text] [Related]
17. Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serum.
Lindqvist D; Kaufman E; Brundin L; Hall S; Surova Y; Hansson O
PLoS One; 2012; 7(10):e47387. PubMed ID: 23082161
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the non-motor items of the MDS-UPDRS and Quality of Life in patients with Parkinson's disease.
Skorvanek M; Rosenberger J; Minar M; Grofik M; Han V; Groothoff JW; Valkovic P; Gdovinova Z; van Dijk JP
J Neurol Sci; 2015; 353(1-2):87-91. PubMed ID: 25918077
[TBL] [Abstract][Full Text] [Related]
19. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression.
Li N; Pan X; Zhang J; Ma A; Yang S; Ma J; Xie A
Neurol Sci; 2017 May; 38(5):761-767. PubMed ID: 28181066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
